Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bram De Wilde

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Journal of Imaging|March 28, 2023
Inter- and Intra-Observer Variability and the Effect of Experience in Cine-MRI for Adhesion DetectionBram de Wilde, Frank Joosten, Wulphert Venderink, et al.
Frontiers in Oncology|September 4, 2023
Case series on clinical applications of liquid biopsy in pediatric solid tumors: towards improved diagnostics and disease monitoringNina U Gelineau, Astrid van Barneveld, Atia Samim, et al.
European Journal of Cancer (Oxford, England : 1990)|October 31, 2020
Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortiumAlba Rubio-San-Simón, Nicolas André, Maria Giuseppina Cefalo, et al.
Acta Neuropathologica|October 11, 2025
Molecular characterization and clinical features of diffuse midline glioma in the pediatric precision oncology registry INFORMElke Pfaff, Kathrin Schramm, Mirjam Blattner-Johnson, et al.
European Journal of Cancer (Oxford, England : 1990)|July 13, 2020
Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe NeuroblastomaLucas Moreno, Giuseppe Barone, Steven G DuBois, et al.
Science Advances|July 20, 2022
RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibitionCarolina Nunes, Lisa Depestel, Liselot Mus, et al.
NPJ Precision Oncology|December 27, 2022
Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORMHeike Peterziel, Nora Jamaladdin, Dina ElHarouni, et al.
Science (New York, N.Y.)|December 8, 2018
A mechanistic classification of clinical phenotypes in neuroblastomaSandra Ackermann, Maria Cartolano, Barbara Hero, et al.
Radiology|July 31, 2020
Automated Assessment of COVID-19 Reporting and Data System and Chest CT Severity Scores in Patients Suspected of Having COVID-19 Using Artificial IntelligenceNikolas Lessmann, Clara I Sánchez, Ludo Beenen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 12, 2025
Dinutuximab Beta Added to Temozolomide-Based Chemotherapy for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON Immuno Phase II TrialJuliet C Gray, Rebekah Weston, Cormac Owens, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Journal of Imaging|March 28, 2023
Inter- and Intra-Observer Variability and the Effect of Experience in Cine-MRI for Adhesion DetectionBram de Wilde, Frank Joosten, Wulphert Venderink, et al.
Frontiers in Oncology|September 4, 2023
Case series on clinical applications of liquid biopsy in pediatric solid tumors: towards improved diagnostics and disease monitoringNina U Gelineau, Astrid van Barneveld, Atia Samim, et al.
European Journal of Cancer (Oxford, England : 1990)|October 31, 2020
Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortiumAlba Rubio-San-Simón, Nicolas André, Maria Giuseppina Cefalo, et al.
Acta Neuropathologica|October 11, 2025
Molecular characterization and clinical features of diffuse midline glioma in the pediatric precision oncology registry INFORMElke Pfaff, Kathrin Schramm, Mirjam Blattner-Johnson, et al.
European Journal of Cancer (Oxford, England : 1990)|July 13, 2020
Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe NeuroblastomaLucas Moreno, Giuseppe Barone, Steven G DuBois, et al.
Science Advances|July 20, 2022
RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibitionCarolina Nunes, Lisa Depestel, Liselot Mus, et al.
NPJ Precision Oncology|December 27, 2022
Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORMHeike Peterziel, Nora Jamaladdin, Dina ElHarouni, et al.
Science (New York, N.Y.)|December 8, 2018
A mechanistic classification of clinical phenotypes in neuroblastomaSandra Ackermann, Maria Cartolano, Barbara Hero, et al.
Radiology|July 31, 2020
Automated Assessment of COVID-19 Reporting and Data System and Chest CT Severity Scores in Patients Suspected of Having COVID-19 Using Artificial IntelligenceNikolas Lessmann, Clara I Sánchez, Ludo Beenen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 12, 2025
Dinutuximab Beta Added to Temozolomide-Based Chemotherapy for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON Immuno Phase II TrialJuliet C Gray, Rebekah Weston, Cormac Owens, et al.
Pageof 7